Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group

Reshma Mahtani; Arturo Loaiza-Bonilla; Al B. Benson; Axel F Grothey; Misagh Karimi; Samuel J. Klempner; Daniel Lin; Heloisa P. Soares

Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group

Reshma Mahtani, Arturo Loaiza-Bonilla, Al B. Benson, Axel F Grothey, Misagh Karimi, Samuel J. Klempner, Daniel Lin, Heloisa P. Soares

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	The Oncologist
Volume	26
State	Published - 2021

Disciplines

Medicine and Health Sciences

Cite this

@article{8367c6d0586f447a8735746e3575b00f,

title = "Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group",

author = "Reshma Mahtani and Arturo Loaiza-Bonilla and Benson, \{Al B.\} and Grothey, \{Axel F\} and Misagh Karimi and Klempner, \{Samuel J.\} and Daniel Lin and Soares, \{Heloisa P.\}",

note = "The use of genomic testing is rapidly emerging as an important clinical tool both for cancer diagnosis and for guiding treatment decisions in a wide range of malignancies, including gastrointestinal (GI) cancers such as colorectal cancer (CRC). Advances in technologies such as polymerase chain react ...",

year = "2021",

language = "American English",

volume = "26",

journal = "The Oncologist",

}

TY - JOUR

T1 - Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group

AU - Mahtani, Reshma

AU - Loaiza-Bonilla, Arturo

AU - Benson, Al B.

AU - Grothey, Axel F

AU - Karimi, Misagh

AU - Klempner, Samuel J.

AU - Lin, Daniel

AU - Soares, Heloisa P.

N1 - The use of genomic testing is rapidly emerging as an important clinical tool both for cancer diagnosis and for guiding treatment decisions in a wide range of malignancies, including gastrointestinal (GI) cancers such as colorectal cancer (CRC). Advances in technologies such as polymerase chain react ...

PY - 2021

Y1 - 2021

UR - https://pubmed.ncbi.nlm.nih.gov/33650740/

M3 - Article

VL - 26

JO - The Oncologist

JF - The Oncologist

ER -

Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group

Disciplines

Other files and links

Cite this